Notably, β-lap promoted HMGB1-depedent immunogenicity and activated innate sensing to bridge innate and adaptive immune response, and markedly shrunk the tumor mass, and is thus a promising partner for combination with immunotherapy. This evidence concerns the gene HMGB1 and neoplasm.